Lagevrio Prices, Coupons, Copay Cards & Patient Assistance
Lagevrio (molnupiravir) is a member of the miscellaneous antivirals drug class and is commonly used for COVID-19.
The cost for Lagevrio 200 mg oral capsule is around $10 for a supply of 40 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Lagevrio prices
Oral Capsule
200 mg
Lagevrio oral capsule
from $10.01
for 40 capsules
Quantity | Per unit | Price |
---|---|---|
40 | $0.25 – $26.86 | $10.01 – $1,074.53 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Lagevrio Coupons, Copay Cards and Rebates
Lagevrio offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
No manufacturer promotions could be found for this medication.
Patient Assistance & Copay Programs for Lagevrio
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Merck Patient Assistance Program
Eligibility requirements:- Must be uninsured or underinsured
- At or below 400% of FPL
- Not specified
- Must be residing in the US or a US territory, and under the care of a US physician
- At Merck we realize that sometimes exceptions need to be made based on the patient's individual circumstances. Individuals who do not meet the insurance criteria may still qualify for the Merck Patient Assistance Program if they attest that they have special circumstances of financial hardship, and their income meets the program criteria. *The Enrollment Form must be mailed. Please do not fax. Call for most recent medications as the list is subject to change.
- Lagevrio (molnupiravir) Capsule
More information please phone: 800-727-5400 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Paxlovid
PAXLOVID (nirmatrelvir with ritonavir) is an antiviral medication used to treat COVID-19. Includes ...
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Tyenne
Tyenne is approved to treat adults with moderately to severely active rheumatoid arthritis, Giant ...
Olumiant
Olumiant is used to treat rheumatoid arthritis, alopecia areata (hair loss), and COVID-19. Includes ...
Kineret
Kineret is used to treat the symptoms of moderate to severe rheumatoid arthritis ...
Anakinra
Anakinra systemic is used for COVID-19, cryopyrin-associated periodic syndromes, interleukin-1 ...
Baricitinib
Baricitinib (brand name Olumiant) is used to treat rheumatoid arthritis, alopecia areata (hair ...
Nirmatrelvir/ritonavir
Nirmatrelvir/ritonavir systemic is used for COVID-19
Tocilizumab
Tocilizumab systemic is used for COVID-19, cytokine release syndrome, giant cell arteritis ...
More about Lagevrio (molnupiravir)
- Compare alternatives
- Reviews (13)
- Drug images
- Side effects
- Dosage information
- Drug class: miscellaneous antivirals
- Breastfeeding
- En español